ArticleJournal of medicinal chemistry2023

Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer.

Xin Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.